Wiese, J. G., Shlipak, M. G., & Browner, W. S. (2000). The Alcohol Hangover. Annals of Internal Medicine, 132(11), 897. https://doi.org/10.7326/0003-4819-132-11-200006060-00008
Viñals, X., Moreno, E., Lanfumey, L., Cordomí, A., Pastor, A., de la Torre, R., . . . Robledo, P. (2015). Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. PLOS Biology, 13(7), e1002194. https://doi.org/10.1371/journal.pbio.1002194
Pope, H. (1995). The residual neuropsychological effects of cannabis: the current status of research. Drug and Alcohol Dependence, 38(1), 25–34. https://doi.org/10.1016/0376-8716(95)01097-i
Thompson, M. D., Martin, R. C., Grayson, L. P., Ampah, S. B., Cutter, G., Szaflarski, J. P., & Bebin, E. M. (2020). Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy. Epilepsy & Behavior, 111, 107299. https://doi.org/10.1016/j.yebeh.2020.107299
Osborne, A. L., Solowij, N., & Weston-Green, K. (2017). A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia. Neuroscience & Biobehavioral Reviews, 72, 310–324. https://doi.org/10.1016/j.neubiorev.2016.11.012
Linares, I. M. P., Guimaraes, F. S., Eckeli, A., Crippa, A. C. S., Zuardi, A. W., Souza, J. D. S., . . . Crippa, J. A. S. (2018). No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Frontiers in Pharmacology, 9. Published. https://doi.org/10.3389/fphar.2018.00315
Cheng, D., Spiro, A. S., Jenner, A. M., Garner, B., & Karl, T. (2014). Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer’s Disease Transgenic Mice. Journal of Alzheimer’s Disease, 42(4), 1383–1396. https://doi.org/10.3233/jad-140921
Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V. (2010). Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. British Journal of Psychiatry, 197(4), 285–290. https://doi.org/10.1192/bjp.bp.110.077503
Freedman, D. A., & Patel, A. D. (2018). Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products. Pediatric Neurology Briefs, 32(0), 3. https://doi.org/10.15844/pedneurbriefs-32-3
Bonn-Miller, M. O., Loflin, M. J. E., Thomas, B. F., Marcu, J. P., Hyke, T., & Vandrey, R. (2017). Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA, 318(17), 1708. https://doi.org/10.1001/jama.2017.11909
Consroe, P., Carlini, E. A., Zwicker, A. P., & Lacerda, L. A. (1979). Interaction of cannabidiol and alcohol in humans. Psychopharmacology, 66(1), 45–50. https://doi.org/10.1007/bf00431988
Nona, C. N., Hendershot, C. S., & le Foll, B. (2019). Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research. Experimental and Clinical Psychopharmacology, 27(4), 359–369. https://doi.org/10.1037/pha0000272
Grimison, P., Mersiades, A., Kirby, A., Lintzeris, N., Morton, R., Haber, P., . . . Stockler, M. (2020). Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Annals of Oncology, 31(11), 1553–1560. https://doi.org/10.1016/j.annonc.2020.07.020
Rock, E. M., Sullivan, M. T., Collins, S. A., Goodman, H., Limebeer, C. L., Mechoulam, R., & Parker, L. A. (2020). Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews. Psychopharmacology, 237(9), 2621–2631. https://doi.org/10.1007/s00213-020-05559-z
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., . . . McGuire, P. K. (2009). Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology. Neuropsychopharmacology, 35(3), 764–774. https://doi.org/10.1038/npp.2009.184
Englund, A., Morrison, P. D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., . . . Kapur, S. (2012). Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology, 27(1), 19–27. https://doi.org/10.1177/0269881112460109
Beale, C., Broyd, S. J., Chye, Y., Suo, C., Schira, M., Galettis, P., . . . Solowij, N. (2018). Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users. Cannabis and Cannabinoid Research, 3(1), 94–107. https://doi.org/10.1089/can.2017.0047